부산대학교 도서관

Kim DY; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.; Peacker BL; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; Dang TM; Department of Dermatology, University of California San Diego, La Jolla, California.; Shinohara MM; Department of Dermatology, University of Washington, Seattle, Washington.; Shahriari N; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.; Stephen S; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.; Chen ST; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; LeBoeuf NR; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: nleboeuf@partners.org.; Larocca C; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE; In Process

Choi S; The Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.; UMass Chan Medical School, Worcester, MA, USA.; Fay CJ; The Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.; Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Devlin PM; The Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.; LeBoeuf NR; The Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process

Florez N; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; LeBoeuf NR; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Rotow J; Dana-Farber Cancer Institute, Boston, MA, USA.; Marks JA; Dana-Farber Cancer Institute, Boston, MA, USA.; Sabari JK; NYU Langone Health, New York, NY, USA.; Arrieta O; Instituto Nacional de Cancerología, Mexico City, Mexico.; Baldotto C; Instituto D'or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil.; Gosain R; Wilmot Cancer Institute, University of Rochester, Rochester, NY, USA.; Zawisza D; Princess Margaret Cancer Centre, Toronto, ON, Canada.; McDonald S; Dana-Farber Cancer Institute, Boston, MA, USA.; Dylgjeri E; Johnson & Johnson, Horsham, PA, USA.; Cifuentes P; Johnson & Johnson, Horsham, PA, USA.; McLellan B; Montefiore Medical Center, New York, NY, USA.; Leighl NB; Princess Margaret Cancer Centre, Toronto, ON, Canada.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Rajeh A; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Roster K; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Reynolds KL; Department of Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; LeBoeuf NR; Department of Dermatology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Sullivan RJ; Department of Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Kwatra SG; Department of Dermatology, Johns Hopkins University, Baltimore, Maryland, USA.; Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE; In Process

Riew GJ; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Guggina LM; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Repetto F; Harvard Medical School, Boston, Massachusetts; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Lian CG; Harvard Medical School, Boston, Massachusetts; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Charrow AP; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; LeBoeuf NR; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Shi CR; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. Electronic address: cshi@bwh.harvard.edu.

Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE; In Process

Riew GJ; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Hijaz BA; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Haq R; Harvard Medical School, Boston, Massachusetts; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Chen ST; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; LeBoeuf NR; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Shi CR; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. Electronic address: cshi@bwh.harvard.edu.

Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE; In Process

Kim DY; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; The Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.; Dang TM; Department of Dermatology, University of California San Diego, La Jolla, California.; Huang JT; Harvard Medical School, Boston, Massachusetts; Dermatology Section, Boston Children's Hospital, Boston, Massachussets.; Stephen S; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; The Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.; Kupper TS; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; The Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.; Larocca C; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; The Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.; LeBoeuf NR; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; The Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: nleboeuf@partners.org.

Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE

Larocca C; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; Bui AN; Harvard Medical School, Boston, MA, USA.; O'Malley JT; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; Giobbie-Hurder A; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Tawa M; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; Teague JE; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Clark RA; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; Cutler C; Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; Jacobsen E; Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; Fisher DC; Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; Kupper TS; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; LeBoeuf NR; Harvard Medical School, Boston, MA, USA. nleboeuf@bwh.harvard.edu.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. nleboeuf@bwh.harvard.edu.; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA. nleboeuf@bwh.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Cheng D; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nguyen NTT; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Thang CJ; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Burke OM; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.; LeBoeuf NR; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Theodosakis N; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; Semenov YR; Department of Dermatology, Harvard Medical School, Boston, Massachusetts.; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774762 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3287 (Electronic) Linking ISSN: 26663287 NLM ISO Abbreviation: JAAD Int Subsets: PubMed not MEDLINE

Hijaz BA; Harvard Medical School, Boston, Massachusetts.; Braun N; Harvard Medical School, Boston, Massachusetts.; Reynolds KL; Harvard Medical School, Boston, Massachusetts; Department of Oncology, Massachusetts General Hospital, Boston, Massachusetts.; Semenov YR; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts.; LeBoeuf NR; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Boston, Massachusetts.; Chen ST; Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: stchen@mgb.org.

Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE; In Process

Qin Q; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Ostendorf L; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; Wells SL; Division of Renal Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Gao C; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.; Tran M; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.; Alikhan FM; Division of Renal Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Zhang X; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.; Chewcharat A; Division of Renal Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Rider RS; Division of Renal Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Prell SA; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.; Chowdhury RB; Harvard Medical School, Boston, MA, USA.; Division of Renal Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Adult Survivorship Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Weins A; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Shah SI; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Mistry K; Harvard Medical School, Boston, MA, USA.; Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Bowman T; Dana-Farber/Harvard Cancer Center, Boston, MA, USA.; Villani AC; Department of Medicine, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.; LeBoeuf NR; Harvard Medical School, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Selamet U; Department of Medicine, Dana-Farber/Harvard Cancer Center, Boston, MA, USA.; Ravi KS; Division of Renal Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Sharon E; Department of Medicine, Dana-Farber/Harvard Cancer Center, Boston, MA, USA.; Leaf DE; Harvard Medical School, Boston, MA, USA.; Division of Renal Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Moledina DG; Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Sise ME; Division of Nephrology, Department of Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.; De Vlaminck I; Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.; Rao DA; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Wei K; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Gupta S; Harvard Medical School, Boston, MA, USA.; Division of Renal Medicine, Department of Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Adult Survivorship Program, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Tang K; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Rajeh A; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Shaw KS; Department of Dermatology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA.; Nguyen N; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Wan G; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Hashemi KB; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Castillo RL; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Kwatra SG; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; LeBoeuf NR; Dana Farber Cancer Institute, Department of Dermatology, Boston, MA, USA.; Ann Vleugels R; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Semenov YR; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Shimony S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Gangat N; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.; LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Cutaneous Oncology, Dana-Farber/Brigham Cancer Center, Boston, Massachusetts, USA.; Feraco AM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.; Lane AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Said JT; Departments of Dermatology.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology.; Iriarte C; Departments of Dermatology.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology.; Talia J; Departments of Dermatology.; Leung B; Departments of Dermatology.; Center for Cutaneous Oncology.; Virgen CA; Departments of Dermatology.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology.; Robertson M; Harvard Medical School, Boston, MA, USA.; Radiology, Brigham and Women's Hospital, Boston, MA, USA.; Rabin MS; Harvard Medical School, Boston, MA, USA.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Larocca C; Departments of Dermatology.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology.; LeBoeuf NR; Departments of Dermatology.; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology.

Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print Cited Medium: Internet ISSN: 1365-2230 (Electronic) Linking ISSN: 03076938 NLM ISO Abbreviation: Clin Exp Dermatol Subsets: MEDLINE

Fay CJ; Department of Dermatology, Brigham and Women's Hospital, and the Center for Cutaneous Oncology, Dana-Farber/Brigham Cancer Center, Boston, Massachusetts.; Hirner JP; Department of Dermatology, University of Missouri Health Care, Columbia, Missouri.; Shimony S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Israel.; Bui AT; Department of Dermatology, Stanford University Medical Center, Stanford, California.; Lane AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.; LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, and the Center for Cutaneous Oncology, Dana-Farber/Brigham Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: nleboeuf@bwh.harvard.edu.

Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE; In Process

Wan G; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Khattab S; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Leung BW; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA.; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute, Boston, MA.; Zhang S; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Nguyen N; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Tran M; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Lin C; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Chang C; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Alexander N; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Jairath R; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Phillipps J; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Tang K; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Rajeh A; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Zubiri L; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Chen ST; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Demehri S; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Yu KH; Harvard Medical School, Boston, MA.; Gusev A; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute, Boston, MA.; Kwatra SG; Department of Dermatology, Johns Hopkins University, Baltimore, MD, USA.; LeBoeuf NR; Harvard Medical School, Boston, MA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA.; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber Cancer Institute, Boston, MA.; Reynolds KL; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Bang AS; Department of Dermatology, Weill Cornell Medicine, New York, NY, USA.; Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Dermatology, Stanford University, Palo Alto, CA, USA.; Fay CJ; Dermatology of Dermatology, Harvard Medical School, Center for Cutaneous Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA, USA.; LeBoeuf NR; Dermatology of Dermatology, Harvard Medical School, Center for Cutaneous Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Boston, MA, USA.; Etaee F; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.; Leventhal JS; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.; Sibaud V; Oncodermatology Department, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.; Arbesman J; Department of Dermatology, Cleveland Clinic, Cleveland, OH, USA.; Wang JY; Department of Dermatology, Stanford University, Palo Alto, CA, USA.; Kwong BY; Department of Dermatology, Stanford University, Palo Alto, CA, USA. bernicek@stanford.edu.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Braun DA; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. david.braun@yale.edu.; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. david.braun@yale.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. david.braun@yale.edu.; Moranzoni G; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Chea V; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; McGregor BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Blass E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Tu CR; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Vanasse AP; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Forman C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Forman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Afeyan AB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Schindler NR; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Liu Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Li S; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Southard J; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Chang SL; Harvard Medical School, Boston, MA, USA.; Department of Urology, Brigham and Women's Hospital, Boston, MA, USA.; Hirsch MS; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; LeBoeuf NR; Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber Brigham and Women's Cancer Center, Boston, MA, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.; Olive O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Mehndiratta A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Greenslade H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Shetty K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Klaeger S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Sarkizova S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Pedersen CB; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Center for Genomic Medicine, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.; Mossanen M; Harvard Medical School, Boston, MA, USA.; Department of Urology, Brigham and Women's Hospital, Boston, MA, USA.; Carulli I; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Tarren A; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Duke-Cohan J; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Howard AA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Iorgulescu JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Molecular Diagnostics Laboratory, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shim B; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Simon JM; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Signoretti S; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Aster JC; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Elagina L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Carr SA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Leshchiner I; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, USA.; Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Gabriel S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Hacohen N; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Olsen LR; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Livak KJ; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Shukla SA; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Fritsch EF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. catherine_wu@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. catherine_wu@dfci.harvard.edu.; Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Computer Science, Metropolitan College, Boston University, Boston, MA, USA.; Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. toni_choueiri@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. toni_choueiri@dfci.harvard.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Wan G; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Nguyen N; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Lu C; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Khattab S; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Yan B; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Amadife M; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Leung BW; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Chen W; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Rajeh A; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Tang K; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Thang C; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Boland G; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.; Reynolds KL; Department of Medicine, Division of Oncology, Massachusetts General Hospital, Boston, MA.; Yu KH; Department of Biomedical Informatics, Harvard Medical School, Boston, MA.; Gusev A; Department of Medicine, Dana-Farber Cancer Institute, Boston, MA.; LeBoeuf NR; Department of Dermatology, Center for Cutaneous Oncology, Dana-Farber/Brigham Cancer Center, Harvard Medical School, Boston, MA.; Kwatra SG; Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD.; Semenov YR; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.

Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Khattab S; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Wan G; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.; Xu S; Brigham and Women's Hospital, Boston, Massachusetts, USA.; Moseley C; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Tran M; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Beagles E; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Lin C; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.; Leung BW; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Azin M; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Hao N; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.; Reynolds KL; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Demehri S; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; LeBoeuf NR; Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dermatology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Semenov YR; Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA YSEMENOV@mgh.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE